GeoVax Labs, Inc. (GOVX)
GOVX Stock Price Chart
Explore GeoVax Labs, Inc. interactive price chart. Choose custom timeframes to analyze GOVX price movements and trends.
GOVX Company Profile
Discover essential business fundamentals and corporate details for GeoVax Labs, Inc. (GOVX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Sept 2020
Employees
17.00
Website
https://www.geovax.comCEO
David Alan Dodd
Description
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
GOVX Financial Timeline
Browse a chronological timeline of GeoVax Labs, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Jul 2026
EPS estimate is -$2.16.
Earnings released on 14 May 2026
EPS came in at -$2.62 falling short of the estimated -$1.60 by -63.75%.
Earnings released on 2 Apr 2026
EPS came in at -$2.29 surpassing the estimated -$4.71 by +51.35%.
Stock split effective on 12 Jan 2026
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2025
EPS came in at -$7.75 falling short of the estimated -$6.00 by -29.17%.
Earnings released on 28 Jul 2025
EPS came in at -$0.35 surpassing the estimated -$0.41 by +14.63%, while revenue for the quarter reached $852.28k , beating expectations by +9.82%.
Earnings released on 1 May 2025
EPS came in at -$0.45 surpassing the estimated -$0.59 by +23.73%, while revenue for the quarter reached $1.64m , beating expectations by +346.41%.
Earnings released on 27 Mar 2025
EPS came in at -$0.30 surpassing the estimated -$0.79 by +62.03%, while revenue for the quarter reached $864.42k , missing expectations by -63.68%.
Earnings released on 12 Nov 2024
EPS came in at -$0.91 surpassing the estimated -$1.29 by +29.46%, while revenue for the quarter reached $2.79m , beating expectations by +203.20%.
Earnings released on 6 Aug 2024
EPS came in at -$1.99 surpassing the estimated -$2.57 by +22.57%, while revenue for the quarter reached $300.68k .
Earnings released on 14 May 2024
EPS came in at -$2.47 surpassing the estimated -$5.56 by +55.58%.
Earnings released on 29 Feb 2024
EPS came in at -$13.60 falling short of the estimated -$2.78 by -389.21%.
Stock split effective on 31 Jan 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -$4.80 falling short of the estimated -$2.55 by -88.24%.
Earnings released on 9 Aug 2023
EPS came in at -$3.30 falling short of the estimated -$2.40 by -37.50%.
Earnings released on 4 May 2023
EPS came in at -$2.25 surpassing the estimated -$2.85 by +21.05%.
Earnings released on 23 Mar 2023
EPS came in at -$74.96 falling short of the estimated -$0.17 by -43.99k%.
Earnings released on 9 Nov 2022
EPS came in at -$2.55 falling short of the estimated -$1.80 by -41.67%.
Earnings released on 3 Aug 2022
EPS came in at -$2.70 falling short of the estimated -$0.32 by -743.75%.
Earnings released on 27 Apr 2022
EPS came in at -$5.10 falling short of the estimated -$0.31 by -1.55k%, while revenue for the quarter reached $81.53k .
Earnings released on 9 Mar 2022
EPS came in at -$33.58 falling short of the estimated -$0.40 by -8.29k%, while revenue for the quarter reached $164.96k .
Earnings released on 11 Nov 2021
EPS came in at -$4.65 falling short of the estimated -$0.37 by -1.16k%, while revenue for the quarter reached $30.41k .
Earnings released on 11 Aug 2021
EPS came in at -$3.15 falling short of the estimated -$0.43 by -632.56%, while revenue for the quarter reached $79.71k , missing expectations by -27.54%.
GOVX Stock Performance
Access detailed GOVX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
